Drugmaker Emergent BioSolutions is partnering with New York City-based Mount Sinai to test its experimental COVID-19 hyperimmune globulin treatment, COVID-HIG. Funded by $34.6 million from the ...

Researchers now recognize eight different trajectories after COVID infection; some are severely ill many months later.

An analysis of medical records from a hospital system in the Bronx, New York, adds to findings linking SARS-CoV-2 infection to later diagnosis of thyroid conditions.

COVID-19 vaccinations were shown to reduce virus-related hospitalizations and severe disease-associated outcomes in immunocompetent adults. The findings from a recently published JAMA Network Open ...

(Reuters) - Dr. Gopi Patel recalls how powerless she felt when New York's Mount Sinai Hospital overflowed with COVID-19 patients in March. Guidance on how to treat the disease was scant, and medical ...

As we mark the fourth anniversary of Covid-19, the pandemic may seem like a distant memory for most people. With widely available vaccines and treatment options, life has returned to normal in many ...

PHOENIX -- First-line treatment with methylprednisolone and second-line treatment with tocilizumab (Actemra) shortened hospital stays for children with pediatric multisystem inflammatory syndrome ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...